Consistent with this, the levels of IFN-γ, TNF-α and IL-6 significantly increased in the serum of mice from the Bif@PAu-NPs + NIR + GM-CSF group compared to the other groups, indicating that a robust anti-tumor immune response triggered by the combination treatment (Fig. 8E-G). This evidence concerns the gene CSF2 and neoplasm.